Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-11-15.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Apr 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cosette Pharmaceuticals, Inc. | 15 Nov 2024 | Human Drugs | |
| Amneal Pharmaceuticals Private Limited | 19 Jul 2024 | Human Drugs | |
| Intas Pharmaceuticals Limited | 12 Jul 2024 | Human Drugs | |
| VerGo Pharma Research Pvt., Ltd | 10 May 2024 | Human Drugs | |
| Alphapharm Pty Ltd | 3 May 2024 | Human Drugs |
Sites inspected
Cosette Pharmaceuticals, Inc.South Plainfield, United States1 insp.
Amneal Pharmaceuticals Private LimitedMatoda, India1 insp.
Intas Pharmaceuticals LimitedAhmedabad, India1 insp.
VerGo Pharma Research Pvt., LtdCorlim, India1 insp.
Alphapharm Pty LtdCarole Park, Australia1 insp.
Co-investigators
Investigators who share inspections with this person.
Ruben C Ayala3 shared
Nicola M Fenty-Stewart3 shared
Arindam Dasgupta2 shared
Yiying E Chen1 shared
Mark W Babbitt1 shared
Janet B Abt1 shared
Full investigator report
Get the verbatim findings behind Li-Hong P Yeh's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site